CME webinar: Suicide and Depression in the Primary Care Office (recorded)
Mar. 2023Education/Webinars
"What the webinar will cover*
Presenters:
Geoff Neimark, MD
Chief Medical Officer
Community Care Behavioral Health Organization
Nicholas DeGregorio, MD, MMM, FACP
AVP, Medicaid Medical Services
UPMC Health Plan
Watch now
Watch the recording of the Suicide and Depression in the Primary Care Office webinar.
Provider is responsible for verifying continuing medical education (CME) eligibility.
*This activity is approved for AMA PRA Category 1.5 Credits™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
- Information on the prevalence of depression, suicide, and suicidal thoughts and behaviors from a state and national perspective
- How to incorporate routine screenings for depression and suicide into daily practice
- A multipronged approach in the treatment for depression and suicide in primary care
- How to determine when and how to refer to behavioral health services
- The spectrum of UPMC Health Plan resources that support behavioral health conditions
Presenters:
Geoff Neimark, MD
Chief Medical Officer
Community Care Behavioral Health Organization
Nicholas DeGregorio, MD, MMM, FACP
AVP, Medicaid Medical Services
UPMC Health Plan
Watch now
Watch the recording of the Suicide and Depression in the Primary Care Office webinar.
Provider is responsible for verifying continuing medical education (CME) eligibility.
*This activity is approved for AMA PRA Category 1.5 Credits™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
Recent Announcements
Voluntary nationwide recall: Atorvastatin (Alkem – October)
Ascend Laboratories LLC is recalling multiple lots of Atorvastatin Calcium Tablets USP. Atorvastatin is used for the treatment of high cholesterol and to reduce the risk of certain cardiovascular events, such as heart attack and stroke.Nov. 2025Pharmacy Updates
October 2025 UPMC for You and UPMC Community HealthChoices formulary update
Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.Oct. 2025Pharmacy Updates
Voluntary nationwide recall: Ocaliva (Intercept – September)
Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).Oct. 2025Pharmacy Updates